<?xml version="1.0" encoding="UTF-8" ?>
<xml>
    <records>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4608</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4608</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Esworthy, R. S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Kim, B. W.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Larson, G. P.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Yip, M. L.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Smith, D. D.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Li, M.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Chu, F. F.</style>
                    </author>
                </authors>
            </contributors>
            <auth-address>
                <style face="normal" font="default" size="100%">Department of Cancer Biology,
                    Beckman Research Institute of City of Hope, Duarte, California.</style>
            </auth-address>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">Colitis locus on chromosome 2
                        impacting the severity of early-onset disease in mice deficient in GPX1 and
                        GPX2</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">Inflammatory Bowel
                        Diseases</style>
                </secondary-title>
                <alt-title>
                    <style face="normal" font="default" size="100%">Inflammatory bowel
                        diseases</style>
                </alt-title>
            </titles>
            <periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Inflammatory Bowel
                        Diseases</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">Inflamm. Bowel Dis.</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">Inflamm Bowel Dis</style>
                </abbr-2>
            </periodical>
            <alt-periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Inflammatory Bowel
                        Diseases</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">Inflamm. Bowel Dis.</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">Inflamm Bowel Dis</style>
                </abbr-2>
            </alt-periodical>
            <pages>
                <style face="normal" font="default" size="100%">1373-86</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">17</style>
            </volume>
            <number>
                <style face="normal" font="default" size="100%">6</style>
            </number>
            <edition>
                <style face="normal" font="default" size="100%">2010/09/28</style>
            </edition>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2011</style>
                </year>
                <pub-dates>
                    <date>
                        <style face="normal" font="default" size="100%">Jun</style>
                    </date>
                </pub-dates>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">1536-4844 (Electronic)&#xD;1078-0998
                    (Linking)</style>
            </isbn>
            <accession-num>
                <style face="normal" font="default" size="100%">20872835</style>
            </accession-num>
            <abstract>
                <style face="normal" font="default" size="100%">BACKGROUND: Genetic background has a
                    profound effect on inflammatory bowel disease. The Gpx1 and Gpx2 double knockout
                    (GPX1/2-DKO) mice on a mixed C57BL/6 (B6) and 129S1/SvimJ (129) background
                    exhibit spontaneous ileocolitis. The DKO mice on a B6 background have mild
                    ileocolitis. We characterized the 129 DKO mice to identify a genetic locus
                    affecting disease severity. METHODS: We backcrossed B6;129 DKO mice to 129 and
                    analyzed for ileocolitis penetrance and severity at N5, N7, and N10. By
                    correlating disease severity with single-nucleotide polymorphism (SNP) markers,
                    we identified a colitis locus. RESULTS: As early as 9 days of age, 129 DKO N5
                    and N10 mice showed disease signs and morbidity. The N10 DKO mice had the
                    severest colitis with nearly complete penetrance and high morbidity compared
                    with other generations or backgrounds. 129 DKO mice had elevated colonic KC and
                    SAA3 expression, shorter colon length, and cecal E. coli overgrowth compared to
                    B6 DKO mice. Analysis of the B6 loci in 129 N5, N7, and N10 cohorts pointed to a
                    region of chromosome 2: 119 Mbp contributing to mild symptoms. CONCLUSIONS:
                    GPX1/2-DKO mice on 129 genetic background have the most aggressive colitis
                    compared to B6;129 and B6 colonies. A B6 locus significantly contributing the
                    resistance resides on chromosome 2: 119 Mbp. This region coincides with
                    cytokine-deficiency-induced colitis susceptibility, Cdcs3, identified in the
                    resistant B6 and sensitive C3H/HeJBir (C3Bir) with IL-10 deficiency. A three-way
                    SNP analysis between 129, B6, and C3Bir locus points the major candidate genes
                    to B2m, Dnajc17, Duox2, Pla2g4b, Pla2g4e, Pla2g4f and Slc30a4. (Inflamm Bowel
                    Dis 2011).</style>
            </abstract>
            <notes>
                <style face="normal" font="default" size="100%">Esworthy, R Steven&#xD;Kim,
                    Byung-Wook&#xD;Larson, Garrett P&#xD;Yip, M L Richard&#xD;Smith, David D&#xD;Li,
                    Min&#xD;Chu, Fong-Fong&#xD;United States&#xD;Inflamm Bowel Dis. 2011
                    Jun;17(6):1373-86. doi: 10.1002/ibd.21479. Epub 2010 Sep 24.</style>
            </notes>
            <urls/>
            <electronic-resource-num>
                <style face="normal" font="default" size="100%">10.1002/ibd.21479</style>
            </electronic-resource-num>
            <remote-database-provider>
                <style face="normal" font="default" size="100%">NLM</style>
            </remote-database-provider>
            <language>
                <style face="normal" font="default" size="100%">eng</style>
            </language>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4626</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4626</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Baker, K. S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Armenian, S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Bhatia, S.</style>
                    </author>
                </authors>
            </contributors>
            <auth-address>
                <style face="normal" font="default" size="100%">Fred Hutchinson Cancer Research
                    Center, Seattle, Washington 98109, USA. ksbaker@fhere.org</style>
            </auth-address>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">Long-term consequences of
                        hematopoietic stem cell transplantation: current state of the
                        science</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">Biology of Blood and Marrow
                        Transplantation</style>
                </secondary-title>
            </titles>
            <periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Biology of Blood and Marrow
                        Transplantation</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">Biol. Blood Marrow
                        Transplant.</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">Biol Blood Marrow
                        Transplant</style>
                </abbr-2>
            </periodical>
            <pages>
                <style face="normal" font="default" size="100%">S90-6</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">16</style>
            </volume>
            <number>
                <style face="normal" font="default" size="100%">1 Suppl</style>
            </number>
            <edition>
                <style face="normal" font="default" size="100%">2009/09/29</style>
            </edition>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">Cardiovascular
                        Diseases/epidemiology/etiology/genetics</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Hematopoietic Stem Cell
                        Transplantation/*adverse effects/*mortality</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Humans</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Metabolic Syndrome
                        X/complications/epidemiology/etiology</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Postoperative
                        Complications/epidemiology/etiology</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Survival Analysis</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2010</style>
                </year>
                <pub-dates>
                    <date>
                        <style face="normal" font="default" size="100%">Jan</style>
                    </date>
                </pub-dates>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">1523-6536 (Electronic)&#xD;1083-8791
                    (Linking)</style>
            </isbn>
            <accession-num>
                <style face="normal" font="default" size="100%">19782145</style>
            </accession-num>
            <notes>
                <style face="normal" font="default" size="100%">Baker, K Scott&#xD;Armenian,
                    Saro&#xD;Bhatia, Smita&#xD;R01 CA 112530-03/CA/NCI NIH HHS/United States&#xD;R01
                    CA078938/CA/NCI NIH HHS/United States&#xD;R01 CA112530-02/CA/NCI NIH HHS/United
                    States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S.
                    Gov&apos;t&#xD;Review&#xD;United States&#xD;Biology of blood and marrow
                    transplantation : journal of the American Society for Blood and Marrow
                    Transplantation&#xD;Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S90-6.
                    Epub 2009 Sep 24.</style>
            </notes>
            <urls>
                <related-urls>
                    <url>
                        <style face="normal" font="default" size="100%"
                            >http://www.ncbi.nlm.nih.gov/pubmed/19782145</style>
                    </url>
                </related-urls>
            </urls>
            <custom2>
                <style face="normal" font="default" size="100%">2832710</style>
            </custom2>
            <electronic-resource-num>
                <style face="normal" font="default" size="100%">S1083-8791(09)00435-2
                    [pii]&#xD;10.1016/j.bbmt.2009.09.017</style>
            </electronic-resource-num>
            <language>
                <style face="normal" font="default" size="100%">eng</style>
            </language>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4612</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4612</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Altorki, N.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Lane, M. E.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Bauer, T.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Lee, P. C.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Guarino, M. J.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Pass, H.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Felip, E.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Peylan-Ramu, N.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Gurpide, A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Grannis, F. W.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Mitchell, J. D.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Tachdjian, S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Swann, R. S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Huff, A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Roychowdhury, D. F.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Reeves, A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Ottesen, L. H.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Yankelevitz, D. F.</style>
                    </author>
                </authors>
            </contributors>
            <auth-address>
                <style face="normal" font="default" size="100%">Weill Medical College, Cornell
                    University, 525 East 68th St, New York, NY 10021, USA.
                    nkaltork@med.cornell.edu</style>
            </auth-address>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">Phase II proof-of-concept study
                        of pazopanib monotherapy in treatment-naive patients with stage I/II
                        resectable non-small-cell lung cancer</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">Journal of Clinical
                        Oncology</style>
                </secondary-title>
                <alt-title>
                    <style face="normal" font="default" size="100%">Journal of clinical oncology :
                        official journal of the American Society of Clinical Oncology</style>
                </alt-title>
            </titles>
            <periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Journal of Clinical
                        Oncology</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">J. Clin. Oncol.</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">J Clin Oncol</style>
                </abbr-2>
            </periodical>
            <pages>
                <style face="normal" font="default" size="100%">3131-7</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">28</style>
            </volume>
            <number>
                <style face="normal" font="default" size="100%">19</style>
            </number>
            <edition>
                <style face="normal" font="default" size="100%">2010/06/03</style>
            </edition>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">Administration, Oral</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Aged</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Aged, 80 and over</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Carcinoma, Non-Small-Cell Lung/
                        drug therapy/genetics</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Diarrhea/chemically
                        induced</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Drug Administration
                        Schedule</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Fatigue/chemically
                        induced</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Female</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Gene Expression
                        Profiling</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Gene Expression Regulation,
                        Neoplastic/drug effects</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Humans</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Hypertension/chemically
                        induced</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Lung Neoplasms/ drug
                        therapy/genetics</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Male</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Middle Aged</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Neoplasm Staging</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Pyrimidines/administration &amp;
                        dosage/adverse effects/ therapeutic use</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Sulfonamides/administration
                        &amp; dosage/adverse effects/ therapeutic use</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Treatment Outcome</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2010</style>
                </year>
                <pub-dates>
                    <date>
                        <style face="normal" font="default" size="100%">Jul 1</style>
                    </date>
                </pub-dates>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">1527-7755 (Electronic)&#xD;0732-183X
                    (Linking)</style>
            </isbn>
            <accession-num>
                <style face="normal" font="default" size="100%">20516450</style>
            </accession-num>
            <abstract>
                <style face="normal" font="default" size="100%">PURPOSE: Patients with early-stage,
                    resectable, non-small-cell lung cancer (NSCLC) are at risk for recurrent
                    disease, and 5-year survival rates do not exceed 75%. Angiogenesis inhibitors
                    have shown clinical activity in patients with late-stage NSCLC, raising the
                    possibility that targeting the vascular endothelial growth factor pathway in
                    earlier-stage disease may be beneficial. This proof-of-concept study examined
                    safety and efficacy of short-term, preoperative pazopanib monotherapy in
                    patients with operable stage I/II NSCLC. PATIENTS AND METHODS: Patients
                    scheduled for resection received oral pazopanib 800 mg/d for 2 to 6 weeks
                    preoperatively. Tumor response was measured by high-resolution computed
                    tomography, permitting estimation of change in tumor volume and diameter.
                    Gene-expression profiling was performed on 77 pre- and post-treatment lung
                    samples from 34 patients. RESULTS: Of 35 patients enrolled, 33 (94%) had
                    clinical stage I NSCLC and two (6%) had clinical stage II NSCLC. Median
                    treatment duration was 16 days (range, 3 to 29 days). Thirty patients (86%)
                    achieved tumor-volume reduction after pazopanib treatment. Two patients achieved
                    tumor-volume reduction &gt; or = 50%, and three patients had partial response
                    according to Response Evaluation Criteria in Solid Tumors. Pazopanib was
                    generally well tolerated. The most common adverse events included grade 2
                    hypertension, diarrhea, and fatigue. One patient developed pulmonary embolism 11
                    days after surgery. Several pazopanib target genes and other angiogenic factors
                    were dysregulated post-treatment. CONCLUSION: Short-duration pazopanib was
                    generally well tolerated and demonstrated single-agent activity in patients with
                    early-stage NSCLC. Several target genes were dysregulated after pazopanib
                    treatment, validating target-specific response and indicating a persistent
                    pazopanib effect on lung cancer tissue. Further clinical evaluation of pazopanib
                    in NSCLC is planned.</style>
            </abstract>
            <notes>
                <style face="normal" font="default" size="100%">Altorki, Nasser&#xD;Lane, Maureen
                    E&#xD;Bauer, Thomas&#xD;Lee, Paul C&#xD;Guarino, Michael J&#xD;Pass,
                    Harvey&#xD;Felip, Enriqueta&#xD;Peylan-Ramu, Nili&#xD;Gurpide,
                    Alfonso&#xD;Grannis, Frederic W&#xD;Mitchell, John D&#xD;Tachdjian,
                    Sabrina&#xD;Swann, R Suzanne&#xD;Huff, Anne&#xD;Roychowdhury, Debasish
                    F&#xD;Reeves, Anthony&#xD;Ottesen, Lone H&#xD;Yankelevitz, David F&#xD;Clinical
                    Trial, Phase II&#xD;Multicenter Study&#xD;Research Support, Non-U.S.
                    Gov&apos;t&#xD;United States&#xD;J Clin Oncol. 2010 Jul 1;28(19):3131-7. Epub
                    2010 Jun 1.</style>
            </notes>
            <urls/>
            <electronic-resource-num>
                <style face="normal" font="default" size="100%">10.1200/jco.2009.23.9749</style>
            </electronic-resource-num>
            <remote-database-provider>
                <style face="normal" font="default" size="100%">NLM</style>
            </remote-database-provider>
            <language>
                <style face="normal" font="default" size="100%">eng</style>
            </language>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4610</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4610</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Podoloff, D. A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Ball, D. W.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Ben-Josef, E.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Benson, A. B., 3rd</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Cohen, S. J.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Coleman, R. E.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Delbeke, D.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Ho, M.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Ilson, D. H.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Kalemkerian, G. P.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Lee, R. J.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Loeffler, J. S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Macapinlac, H. A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Morgan, R. J., Jr.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Siegel, B. A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Singhal, S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Tyler, D. S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Wong, R. J.</style>
                    </author>
                </authors>
            </contributors>
            <auth-address>
                <style face="normal" font="default" size="100%">The University of Texas, M.D.
                    Anderson Cancer Center, Houston, Texas, USA.</style>
            </auth-address>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">NCCN task force: clinical
                        utility of PET in a variety of tumor types</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">J Natl Compr Canc Netw</style>
                </secondary-title>
                <alt-title>
                    <style face="normal" font="default" size="100%">Journal of the National
                        Comprehensive Cancer Network : JNCCN</style>
                </alt-title>
            </titles>
            <periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">J Natl Compr Canc Netw</style>
                </full-title>
            </periodical>
            <alt-periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Journal of the National
                        Comprehensive Cancer Network : JNCCN</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">J Natl Compr Canc Netw</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">J Natl Compr Canc Netw</style>
                </abbr-2>
            </alt-periodical>
            <pages>
                <style face="normal" font="default" size="100%">S1-26</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">7 Suppl 2</style>
            </volume>
            <edition>
                <style face="normal" font="default" size="100%">2009/08/22</style>
            </edition>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">Fluorodeoxyglucose F18/
                        diagnostic use</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Humans</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Neoplasms/classification/
                        radionuclide imaging/therapy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Positron-Emission Tomography/
                        utilization</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Prognosis</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Radiopharmaceuticals/ diagnostic
                        use</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2009</style>
                </year>
                <pub-dates>
                    <date>
                        <style face="normal" font="default" size="100%">Jun</style>
                    </date>
                </pub-dates>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">1540-1405 (Print)&#xD;1540-1405
                    (Linking)</style>
            </isbn>
            <accession-num>
                <style face="normal" font="default" size="100%">19555588</style>
            </accession-num>
            <abstract>
                <style face="normal" font="default" size="100%">Use of PET is widespread and
                    increasing in the United States, mainly for oncologic applications. In November
                    2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of
                    experts to review the literature and develop clinical recommendations for using
                    PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers.
                    However, because its use is not restricted to these diseases, and evidence is
                    accumulating for its application in other types of cancers, NCCN convened a
                    second meeting in December 2008 to expand on the initial report. A
                    multidisciplinary panel met to discuss the current data on PET application for
                    various tumor types, including genitourinary, gynecologic, pancreatic,
                    hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers,
                    and sarcoma and myeloma. This report summarizes the proceedings of this meeting,
                    including discussions of the background of PET, the role of PET in oncology,
                    principles of PET use, emerging applications, and possible future
                    developments.</style>
            </abstract>
            <notes>
                <style face="normal" font="default" size="100%">Podoloff, Donald A&#xD;Ball, Douglas
                    W&#xD;Ben-Josef, Edgar&#xD;Benson, Al B 3rd&#xD;Cohen, Steven J&#xD;Coleman, R
                    Edward&#xD;Delbeke, Dominique&#xD;Ho, Maria&#xD;Ilson, David H&#xD;Kalemkerian,
                    Gregory P&#xD;Lee, Richard J&#xD;Loeffler, Jay S&#xD;Macapinlac, Homer
                    A&#xD;Morgan, Robert J Jr&#xD;Siegel, Barry Alan&#xD;Singhal, Seema&#xD;Tyler,
                    Douglas S&#xD;Wong, Richard J&#xD;Research Support, N.I.H.,
                    Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United
                    States&#xD;J Natl Compr Canc Netw. 2009 Jun;7 Suppl 2:S1-26.</style>
            </notes>
            <urls/>
            <remote-database-provider>
                <style face="normal" font="default" size="100%">NLM</style>
            </remote-database-provider>
            <language>
                <style face="normal" font="default" size="100%">eng</style>
            </language>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4615</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4615</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Chen, Yi-Jen</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Kernstine, Kemp H.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Shibata, Stephen</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Dean, Lim</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Smith, David D.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Tang, Martin </style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Liu, An </style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Pezner, Richard D.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Wong, Jeffrey Y. C.</style>
                    </author>
                </authors>
            </contributors>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">Image-guided Radiotherapy Of
                        Esophageal Cancer By Helical Tomotherapy: Acute Toxicity And Preliminary
                        Clinical Outcome</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">J Thorac Dis</style>
                </secondary-title>
            </titles>
            <pages>
                <style face="normal" font="default" size="100%">11-16</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">1</style>
            </volume>
            <number>
                <style face="normal" font="default" size="100%">1</style>
            </number>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2009</style>
                </year>
            </dates>
            <urls/>
            <custom1>
                <style face="normal" font="default" size="100%">Mannual entered -- June 2011</style>
            </custom1>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>1485</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">1485</key>
                <key app="ENWeb" db-id="SpvuHwrtqggAACRgWhA">1629</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Thompson, K. J.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Kernstine, K. H.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Grannis, F. W., Jr.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Mojica, P.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Falabella, A.</style>
                    </author>
                </authors>
            </contributors>
            <auth-address>
                <style face="normal" font="default" size="100%">City of Hope, Duarte, California
                    91010, USA.</style>
            </auth-address>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">Treatment of chylothorax by
                        robotic thoracic duct ligation</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">Ann Thorac Surg</style>
                </secondary-title>
            </titles>
            <periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Annals of Thoracic
                        Surgery</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">Ann. Thorac. Surg.</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">Ann Thorac Surg</style>
                </abbr-2>
            </periodical>
            <pages>
                <style face="normal" font="default" size="100%">334-6</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">85</style>
            </volume>
            <number>
                <style face="normal" font="default" size="100%">1</style>
            </number>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">Adult</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%"
                        >Chylothorax/etiology/surgery</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Follow-Up Studies</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Humans</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Ligation/instrumentation</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Lung Neoplasms/
                        secondary/surgery</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Male</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Neoplasms, Germ Cell and
                        Embryonal/ secondary/therapy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Orchiectomy/methods</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Pneumonectomy/ adverse
                        effects/methods</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Risk Assessment</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Robotics</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Severity of Illness
                        Index</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Testicular
                        Neoplasms/pathology/therapy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Thoracic Duct/ surgery</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Treatment Outcome</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2008</style>
                </year>
                <pub-dates>
                    <date>
                        <style face="normal" font="default" size="100%">Jan</style>
                    </date>
                </pub-dates>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">1552-6259 (Electronic)</style>
            </isbn>
            <accession-num>
                <style face="normal" font="default" size="100%">18154843</style>
            </accession-num>
            <abstract>
                <style face="normal" font="default" size="100%">This is the first report describing
                    the use of robotic technology for the treatment of chylothorax. We present a
                    22-year-old with mixed embryonal cell and seminoma germ cell cancer refractory
                    to medical and surgical treatment. The patient had rising markers and a growing
                    left lower lung lobe metastasis. After left lower lobectomy, left-sided
                    chylothorax developed. Conservative management failed, and a robotic right-sided
                    thoracic duct ligation was performed. Other treatment options are
                    reviewed.</style>
            </abstract>
            <work-type>
                <style face="normal" font="default" size="100%">Case report</style>
            </work-type>
            <urls/>
            <custom1>
                <style face="normal" font="default" size="100%">PubMed 2009/04/</style>
            </custom1>
            <language>
                <style face="normal" font="default" size="100%">eng</style>
            </language>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4631</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4631</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Lin, R. J.</style>
                    </author>
                </authors>
            </contributors>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">RNA -protein interaction
                        protocols. Preface</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">Methods in Molecular
                        Biology</style>
                </secondary-title>
            </titles>
            <periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Methods in Molecular
                        Biology</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">Methods Mol. Biol.</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">Methods Mol Biol</style>
                </abbr-2>
            </periodical>
            <pages>
                <style face="normal" font="default" size="100%">v-vii</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">488</style>
            </volume>
            <edition>
                <style face="normal" font="default" size="100%">2008/11/07</style>
            </edition>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">Protein Binding</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%"
                        >Proteins/chemistry/*metabolism</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%"
                        >RNA/chemistry/*metabolism</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2008</style>
                </year>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">1064-3745 (Print)&#xD;1064-3745
                    (Linking)</style>
            </isbn>
            <accession-num>
                <style face="normal" font="default" size="100%">18985949</style>
            </accession-num>
            <notes>
                <style face="normal" font="default" size="100%">Lin,
                    Ren-Jang&#xD;Introductory&#xD;United States&#xD;Methods in molecular biology
                    (Clifton, N.J.)&#xD;Methods Mol Biol. 2008;488:v-vii.</style>
            </notes>
            <urls>
                <related-urls>
                    <url>
                        <style face="normal" font="default" size="100%"
                            >http://www.ncbi.nlm.nih.gov/pubmed/18985949</style>
                    </url>
                </related-urls>
            </urls>
            <custom1>
                <style face="normal" font="default" size="100%">Missing CCSG pubs -- June
                    2011</style>
            </custom1>
            <language>
                <style face="normal" font="default" size="100%">eng</style>
            </language>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>1307</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">1307</key>
                <key app="ENWeb" db-id="SpvuHwrtqggAACRgWhA">1945</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Armenian, S. H.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Bhatia, S.</style>
                    </author>
                </authors>
            </contributors>
            <auth-address>
                <style face="normal" font="default" size="100%">Division of Hematology/Oncology,
                    Childrens Hospital Los Angeles, Los Angeles, CA, United States&#xD;Division of
                    Population Sciences, City of Hope National Medical Center, Duarte, CA, United
                    States</style>
            </auth-address>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">Cardiovascular disease after
                        hematopoietic cell transplantation - Lessons learned</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">Haematologica</style>
                </secondary-title>
            </titles>
            <periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Haematologica</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">Haematologica</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">Haematologica</style>
                </abbr-2>
            </periodical>
            <pages>
                <style face="normal" font="default" size="100%">1132-1136</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">93</style>
            </volume>
            <number>
                <style face="normal" font="default" size="100%">8</style>
            </number>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">dipeptidyl carboxypeptidase
                        inhibitor</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">artery disease</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">cardiomyopathy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">cardiovascular disease</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">case control study</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">cerebrovascular disease</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">comorbidity</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">congestive heart failure</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">coronary artery disease</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">counseling</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">diabetes mellitus</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">dyslipidemia</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">echocardiography</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">editorial</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">health education</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">health promotion</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">heart muscle conduction
                        disturbance</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">hematopoietic stem cell
                        transplantation</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">human</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">hypertension</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">obesity</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">outcome assessment</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">pericarditis</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">population</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">practice guideline</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">prevalence</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">retrospective study</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">risk</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">risk factor</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">valvular heart disease</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Anthracyclines</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Cardiomyopathies</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Cardiovascular Diseases</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Hematopoietic Stem Cell
                        Transplantation</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Humans</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Neoplasms</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2008</style>
                </year>
                <pub-dates>
                    <date>
                        <style face="normal" font="default" size="100%">Aug</style>
                    </date>
                </pub-dates>
            </dates>
            <accession-num>
                <style face="normal" font="default" size="100%">10.3324/haematol.13514</style>
            </accession-num>
            <notes>
                <style face="normal" font="default" size="100%">03906078 (ISSN)&#xD;Export Date: 25
                    March 2009&#xD;Source: Scopus&#xD;CODEN: HAEMA&#xD;doi:
                    10.3324/haematol.13514&#xD;Language of Original Document:
                    English&#xD;Correspondence Address: Bhatia, S.; Division of Population Sciences;
                    City of Hope National Medical Center Duarte, CA, United States; email:
                    sbhatia@coh.org&#xD;Chemicals/CAS: Anthracyclines</style>
            </notes>
            <work-type>
                <style face="normal" font="default" size="100%">Editorial</style>
            </work-type>
            <urls>
                <related-urls>
                    <url>
                        <style face="normal" font="default" size="100%"
                            >http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-48749088400&amp;partnerID=40
                        </style>
                    </url>
                </related-urls>
            </urls>
            <custom1>
                <style face="normal" font="default" size="100%">Scopus/</style>
            </custom1>
            <electronic-resource-num>
                <style face="normal" font="default" size="100%">10.3324/haematol.13514</style>
            </electronic-resource-num>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4613</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4613</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Wang, J.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Valo, Z.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Smith, D.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Singer-Sam, J.</style>
                    </author>
                </authors>
            </contributors>
            <auth-address>
                <style face="normal" font="default" size="100%">Division of Biology, Beckman
                    Research Institute, City of Hope National Medical Center, Duarte, California,
                    United States of America.</style>
            </auth-address>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">Monoallelic expression of
                        multiple genes in the CNS</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">PLoS One</style>
                </secondary-title>
            </titles>
            <pages>
                <style face="normal" font="default" size="100%">e1293</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">2</style>
            </volume>
            <number>
                <style face="normal" font="default" size="100%">12</style>
            </number>
            <edition>
                <style face="normal" font="default" size="100%">2007/12/13</style>
            </edition>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">*Alleles</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Animals</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Central Nervous
                        System/*metabolism</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">*Gene Expression</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Humans</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Male</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Mice</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Mice, Inbred C57BL</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Oligonucleotide Array Sequence
                        Analysis</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2007</style>
                </year>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">1932-6203 (Electronic)&#xD;1932-6203
                    (Linking)</style>
            </isbn>
            <accession-num>
                <style face="normal" font="default" size="100%">18074017</style>
            </accession-num>
            <abstract>
                <style face="normal" font="default" size="100%">The inheritance pattern of a number
                    of major genetic disorders suggests the possible involvement of genes that are
                    expressed from one allele and silent on the other, but such genes are difficult
                    to detect. Since DNA methylation in regulatory regions is often a mark of gene
                    silencing, we modified existing microarray-based assays to detect both
                    methylated and unmethylated DNA sequences in the same sample, a variation we
                    term the MAUD assay. We probed a 65 Mb region of mouse Chr 7 for gene-associated
                    sequences that show two distinct DNA methylation patterns in the mouse CNS.
                    Selected genes were then tested for allele-specific expression in clonal neural
                    stem cell lines derived from reciprocal F(1) (C57BL/6xJF1) hybrid mice. In
                    addition, using a separate approach, we directly analyzed allele-specific
                    expression of a group of genes interspersed within clusters of OlfR genes, since
                    the latter are subject to allelic exclusion. Altogether, of the 500 known genes
                    in the chromosomal region surveyed, five show monoallelic expression, four
                    identified by the MAUD assay (Agc1, p (pink-eyed dilution), P4ha3 and Thrsp),
                    and one by its proximity to OlfR genes (Trim12). Thrsp (thyroid hormone
                    responsive SPOT14 homolog) is expressed in hippocampus, but the human protein
                    homolog, S14, has also been implicated in aggressive breast cancer. Monoallelic
                    expression of the five genes is not coordinated at a chromosome-wide level, but
                    rather regulated at individual loci. Taken together, our results suggest that at
                    least 1% of previously untested genes are subject to allelic exclusion, and
                    demonstrate a dual approach to expedite their identification.</style>
            </abstract>
            <notes>
                <style face="normal" font="default" size="100%">Wang, Jinhui&#xD;Valo,
                    Zuzana&#xD;Smith, David&#xD;Singer-Sam, Judith&#xD;R21 MH073754/MH/NIMH NIH
                    HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United
                    States&#xD;PloS one&#xD;PLoS One. 2007 Dec 12;2(12):e1293.</style>
            </notes>
            <urls>
                <related-urls>
                    <url>
                        <style face="normal" font="default" size="100%"
                            >http://www.ncbi.nlm.nih.gov/pubmed/18074017</style>
                    </url>
                </related-urls>
            </urls>
            <custom2>
                <style face="normal" font="default" size="100%">2100171</style>
            </custom2>
            <electronic-resource-num>
                <style face="normal" font="default" size="100%">10.1371/journal.pone.0001293</style>
            </electronic-resource-num>
            <language>
                <style face="normal" font="default" size="100%">eng</style>
            </language>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4611</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4611</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Podoloff, D. A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Advani, R. H.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Allred, C.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Benson, A. B., 3rd</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Brown, E.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Burstein, H. J.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Carlson, R. W.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Coleman, R. E.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Czuczman, M. S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Delbeke, D.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Edge, S. B.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Ettinger, D. S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Grannis, F. W., Jr.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Hillner, B. E.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Hoffman, J. M.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Kiel, K.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Komaki, R.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Larson, S. M.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Mankoff, D. A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Rosenzweig, K. E.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Skibber, J. M.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Yahalom, J.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Yu, J. M.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Zelenetz, A. D.</style>
                    </author>
                </authors>
            </contributors>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">NCCN task force report: positron
                        emission tomography (PET)/computed tomography (CT) scanning in
                        cancer</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">J Natl Compr Canc Netw</style>
                </secondary-title>
                <alt-title>
                    <style face="normal" font="default" size="100%">Journal of the National
                        Comprehensive Cancer Network : JNCCN</style>
                </alt-title>
            </titles>
            <periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">J Natl Compr Canc Netw</style>
                </full-title>
            </periodical>
            <alt-periodical>
                <full-title>
                    <style face="normal" font="default" size="100%">Journal of the National
                        Comprehensive Cancer Network : JNCCN</style>
                </full-title>
                <abbr-1>
                    <style face="normal" font="default" size="100%">J Natl Compr Canc Netw</style>
                </abbr-1>
                <abbr-2>
                    <style face="normal" font="default" size="100%">J Natl Compr Canc Netw</style>
                </abbr-2>
            </alt-periodical>
            <pages>
                <style face="normal" font="default" size="100%">S1-S22; quiz S23-2</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">5 Suppl 1</style>
            </volume>
            <edition>
                <style face="normal" font="default" size="100%">2007/05/19</style>
            </edition>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">Breast
                        Neoplasms/diagnosis/therapy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Carcinoma, Non-Small-Cell
                        Lung/diagnosis/therapy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Colorectal
                        Neoplasms/diagnosis/therapy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Fluorodeoxyglucose
                        F18/diagnostic use</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Humans</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%"
                        >Lymphoma/diagnosis/pathology/therapy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Neoplasm Staging</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Neoplasms/ diagnosis</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Positron-Emission
                        Tomography</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Prognosis</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Tomography, X-Ray
                        Computed</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2007</style>
                </year>
                <pub-dates>
                    <date>
                        <style face="normal" font="default" size="100%">May</style>
                    </date>
                </pub-dates>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">1540-1405 (Print)&#xD;1540-1405
                    (Linking)</style>
            </isbn>
            <accession-num>
                <style face="normal" font="default" size="100%">17509259</style>
            </accession-num>
            <abstract>
                <style face="normal" font="default" size="100%">The use of positron emission
                    tomography (PET) is increasing rapidly in the United States, with the most
                    common use of PET scanning related to oncology. It is especially useful in the
                    staging and management of lymphoma, lung cancer, and colorectal cancer,
                    according to a panel of expert radiologists, surgeons, radiation oncologists,
                    nuclear medicine physicians, medical oncologists, and general internists
                    convened in November 2006 by the National Comprehensive Cancer Network. The Task
                    Force was charged with reviewing existing data and developing clinical
                    recommendations for the use of PET scans in the evaluation and management of
                    breast cancer, colon cancer, non-small cell lung cancer, and lymphoma. This
                    report summarizes the proceedings of this meeting, including discussions of the
                    background of PET, possible future developments, and the role of PET in
                    oncology.</style>
            </abstract>
            <notes>
                <style face="normal" font="default" size="100%">Podoloff, Donald A&#xD;Advani,
                    Ranjana H&#xD;Allred, Craig&#xD;Benson, Al B 3rd&#xD;Brown,
                    Elizabeth&#xD;Burstein, Harold J&#xD;Carlson, Robert W&#xD;Coleman, R
                    Edward&#xD;Czuczman, Myron S&#xD;Delbeke, Dominique&#xD;Edge, Stephen
                    B&#xD;Ettinger, David S&#xD;Grannis, Frederic W Jr&#xD;Hillner, Bruce
                    E&#xD;Hoffman, John M&#xD;Kiel, Krystyna&#xD;Komaki, Ritsuko&#xD;Larson, Steven
                    M&#xD;Mankoff, David A&#xD;Rosenzweig, Kenneth E&#xD;Skibber, John
                    M&#xD;Yahalom, Joachim&#xD;Yu, Jq Michael&#xD;Zelenetz, Andrew D&#xD;United
                    States&#xD;J Natl Compr Canc Netw. 2007 May;5 Suppl 1:S1-S22; quiz
                    S23-2.</style>
            </notes>
            <urls/>
            <remote-database-provider>
                <style face="normal" font="default" size="100%">NLM</style>
            </remote-database-provider>
            <language>
                <style face="normal" font="default" size="100%">eng</style>
            </language>
        </record>
        <record>
            <database name="cummulative-April2011 Copy Copy.enl"
                path="C:\Documents and Settings\alynch\Desktop\cummulative-April2011 Copy Copy.enl"
                >cummulative-April2011 Copy Copy.enl</database>
            <source-app name="EndNote" version="13.0">EndNote</source-app>
            <rec-number>4606</rec-number>
            <foreign-keys>
                <key app="EN" db-id="tvdsrfez22saafe95sg5dfrrfvv2vrx09dx5">4606</key>
            </foreign-keys>
            <ref-type name="Journal Article">17</ref-type>
            <contributors>
                <authors>
                    <author>
                        <style face="normal" font="default" size="100%">Anderson, C. A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Hellan, M.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Falebella, A.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Lau, C. S.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Grannis Jr, F. W.</style>
                    </author>
                    <author>
                        <style face="normal" font="default" size="100%">Kernstine, K. H.</style>
                    </author>
                </authors>
            </contributors>
            <auth-address>
                <style face="normal" font="default" size="100%">Department of Surgical Oncology,
                    City of Hope, Duarte, CA, United States&#xD;Department of Anesthesia, City of
                    Hope, Duarte, CA, United States&#xD;Department of Urologic Oncology, City of
                    Hope, Duarte, CA, United States&#xD;Department of Thoracic Surgery, City of
                    Hope, Duarte, CA, United States&#xD;Department of Thoracic Surgery, City of
                    Hope, Beckman Research Institute, 1500 Duarte Road, Duarte, CA 91010, United
                    States&#xD;Kernstine, K.H.; Department of Thoracic Surgery, City of Hope,
                    Beckman Research Institute, 1500 Duarte Road, Duarte, CA 91010, United States;
                    email: kkernstine@coh.org</style>
            </auth-address>
            <titles>
                <title>
                    <style face="normal" font="default" size="100%">Robotic-assisted lung resection
                        for malignant disease</style>
                </title>
                <secondary-title>
                    <style face="normal" font="default" size="100%">Innovations: Technology and
                        Techniques in Cardiothoracic and Vascular Surgery</style>
                </secondary-title>
                <alt-title>
                    <style face="normal" font="default" size="100%">Innov. Technol. Tech.
                        Cardiothorac. Vasc. Surg.</style>
                </alt-title>
            </titles>
            <pages>
                <style face="normal" font="default" size="100%">254-258</style>
            </pages>
            <volume>
                <style face="normal" font="default" size="100%">2</style>
            </volume>
            <number>
                <style face="normal" font="default" size="100%">5</style>
            </number>
            <keywords>
                <keyword>
                    <style face="normal" font="default" size="100%">Lung cancer</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Minimally invasive lung
                        resection</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Robotic lobectomy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">Robotic technology</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">adult</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">aged</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">article</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">bleeding</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">bronchoscopy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">cancer recurrence</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">cancer surgery</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">clinical article</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">feasibility study</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">female</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">follow up</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">heart atrium
                        fibrillation</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">human</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">human tissue</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">intensive care unit</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">length of stay</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">lung lobectomy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">lung non small cell
                        cancer</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">lung resection</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">lymph node</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">male</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">mediastinoscopy</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">morbidity</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">operation duration</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">pneumonia</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">priority journal</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">retrospective study</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">robotics</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">statistical significance</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">surgical mortality</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">surgical technique</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">tube</style>
                </keyword>
                <keyword>
                    <style face="normal" font="default" size="100%">tumor volume</style>
                </keyword>
            </keywords>
            <dates>
                <year>
                    <style face="normal" font="default" size="100%">2007</style>
                </year>
            </dates>
            <isbn>
                <style face="normal" font="default" size="100%">15569845</style>
            </isbn>
            <abstract>
                <style face="normal" font="default" size="100%">OBJECTIVE: There have been few
                    reports of the use of robotic surgery to resect lung malignancies. Feasibility
                    and safety of robotic lung resection for malignant lung lesions will be assessed
                    by performing a retrospective analysis. METHODS: Between September 2004 and
                    November 2006, 21 patients (11 male and 10 female patients) underwent robotic
                    lung resection. Twenty resections were performed for primary nonsmall cell lung
                    cancer and two for metastatic lesions. One patient had bilateral resections for
                    two primary tumors. Fourteen lobectomies, five segementectomies, one wedge
                    resection, and two bilobectomies were performed. Seventy-two percent of
                    operative procedures included mediastinoscopy and/or bronchoscopy at the time of
                    resection. RESULTS: Thirty-day mortality and conversion rate was 0%. The median
                    operating room time and estimated blood loss was 3.6 hours and 100 mL,
                    respectively. The median intensive care unit and total length of hospital stays
                    were 2 and 4 days, respectively. Chest tubes were removed after a median of 2.0
                    days. The complication rate was 27%, which included atrial fibrillation, need
                    for postoperative bronchoscopy, and pneumonia. The median tumor size and number
                    of lymph nodes harvested was 2.3 cm and 16, respectively. All resection margins
                    were negative. Median follow-up time was 9.8 months, with no local recurrences
                    at this time. CONCLUSION: Robotic lung resection appears safe and feasible and
                    allows for significant lymph node retrieval, offers short hospital stays and low
                    morbidity for patients undergoing surgical resection of lung malignancies.
                    Future studies are needed to define the role of robotic surgery in lung cancer
                    treatment.  2007 Lippincott Williams &amp; Wilkins, Inc.</style>
            </abstract>
            <notes>
                <style face="normal" font="default" size="100%">Export Date: 8 June 2011&#xD;Source:
                    Scopus&#xD;Language of Original Document: English</style>
            </notes>
            <urls>
                <related-urls>
                    <url>
                        <style face="normal" font="default" size="100%"
                            >http://www.scopus.com/inward/record.url?eid=2-s2.0-37349094036&amp;partnerID=40&amp;md5=8c825d41c8c61db81c674a4338909781</style>
                    </url>
                </related-urls>
            </urls>
            <electronic-resource-num>
                <style face="normal" font="default" size="100%">10.1097/IMI.0b013e31815e52f1</style>
            </electronic-resource-num>
        </record>
    </records>
</xml>
